Angiotensin–neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
E Uijl, DC't Hart, LCW Roksnoer… - Journal of …, 2020 - journals.lww.com
Objectives: Combined angiotensin receptor--neprilysin inhibition (ARNI) reduces
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
E Uijl, D C't Hart, LCW Roksnoer… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives Combined angiotensin receptor--neprilysin inhibition (ARNI) reduces
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
[引用][C] Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
E Uijl, DC t Hart, LCW Roksnoer… - 2020 - repository.ubn.ru.nl
OBJECTIVES: Combined angiotensin receptor--neprilysin inhibition (ARNI) reduces
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury.
E Uijl, DC t Hart, LCW Roksnoer… - Journal of …, 2020 - europepmc.org
Objectives Combined angiotensin receptor--neprilysin inhibition (ARNI) reduces
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
[PDF][PDF] Angiotensin^ neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
E Uijla, DC't Hartc, LCW Roksnoera… - Journal of …, 2019 - siditalia.it
Objectives: Combined angiotensin receptor–neprilysin inhibition (ARNI) reduces
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
E Uijl, DC t Hart, L Roksnoer… - Journal of …, 2020 - repub.eur.nl
OBJECTIVES: Combined angiotensin receptor--neprilysin inhibition (ARNI) reduces
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
Angiotensin–neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
E Uijl, DC't Hart, LCW Roksnoer… - Journal of …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objectives:</jats: title>< jats: p> Combined angiotensin receptor--
neprilysin inhibition (ARNI) reduces glomerulosclerosis better than single angiotensin …
neprilysin inhibition (ARNI) reduces glomerulosclerosis better than single angiotensin …
Angiotensin–neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury
E Uijl, DC't Hart, LCW Roksnoer… - Journal of …, 2020 - journals.lww.com
Objectives: Combined angiotensin receptor--neprilysin inhibition (ARNI) reduces
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …
glomerulosclerosis better than single angiotensin receptor blockade (ARB) in diabetic …